Clinical Trials in Los Angeles

Showing 2461-2480 of 14,465 trials

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

NCT03460769

The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT), which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Similar to all studies that will be coordinated and managed by the CDMC, no patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC, which are listed in the appended DETECT protocol. The data management systems, auditing, and monitoring effort are supported by the CDMC.

Pancreatic CancerChronic PancreatitisDiabetes Mellitus Type 3c

M.D. Anderson Cancer Center775 participantsStarted Apr 2021

Los Angeles, California, United States • Stanford, California, United States • Gainesville, Florida, United States +7 more locations

COMPLETEDNA< 1 mile

Lower Extremity BFR-randomized Controlled Trial Healthy Volunteers

NCT05868304

The purpose of this research is to determine the effects of low-load blood flow restriction (BFR) training compared to conventional strengthening using dynamic force plate and isometric force frame analyses in healthy subjects.

Healthy

Cedars-Sinai Medical Center16 participantsStarted Feb 2023

Los Angeles, California, United States

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

Lower Extremity BFR-randomized Controlled Trial Healthy Volunteers

Find Trials by Condition in Los Angeles

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Pragmatic Trial of Psilocybin Therapy in Palliative Care

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

UR+AIMS Gout Wearable Skin Uric Acid Monitor Study

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA